Related Experiment Video
Updated: Aug 12, 2025

Multi-modal Pulmonary Imaging: Using Complementary Information from CT and Hyperpolarized 129Xe MRI to Evaluate Lung Structure-Function
Published on: April 12, 2024
Imaging-derived biomarkers in Asthma: Current status and future perspectives
Esther Pompe1, Anastasia Kal Kwee1, Vickram Tejwani2
1Department of Radiology, University Medical Center Utrecht, Utrecht, the Netherlands.
Asthma imaging, including MRI, can help personalize treatment by identifying distinct patient subtypes. Artificial intelligence shows promise in analyzing these images for better asthma classification and care.
Area of Science:
- Pulmonology and Respiratory Medicine
- Medical Imaging
- Artificial Intelligence in Medicine
Background:
- Asthma affects over 315 million people globally, highlighting the need for personalized treatment strategies.
- Understanding asthma heterogeneity is crucial for tailoring therapies and assessing treatment responses.
- Radiological imaging, including CT and MRI, offers valuable insights into asthma, but quantitative analysis and standardization are needed.
Purpose of the Study:
- To explore the role of quantitative imaging, particularly MRI, in characterizing asthma phenotypes.
- To assess the potential of artificial intelligence (AI) in analyzing medical images for asthma subclassification.
- To identify how advanced imaging techniques can inform personalized asthma management and biologic therapy response.
Main Methods:
- Review of current radiological imaging modalities used in asthma research, including chest X-ray, CT, and MRI.
- Discussion of the potential of quantitative imaging analysis for identifying distinct asthma phenotypes.
- Exploration of early-stage artificial intelligence applications in analyzing asthma imaging data for subclassification.
Main Results:
- Quantitative imaging offers a promising avenue for identifying asthma phenotypes with different disease trajectories and treatment responses.
- Magnetic resonance imaging (MRI) in asthma is primarily used in research due to cost and standardization challenges.
- AI-driven image analysis has shown initial feasibility in subtyping asthma, indicating potential for clinical application.
Conclusions:
- Advanced imaging techniques, especially quantitative MRI, are vital for understanding asthma heterogeneity and personalizing treatment.
- Further research and standardization are required to integrate MRI and AI into routine clinical practice for asthma management.
- AI-powered asthma imaging analysis holds significant potential for improving patient stratification and therapeutic strategies, including the use of biologics.
Related Concept Videos
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-III: Symptoms and Complications
Classification of Asthma
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...

